Thirumagal Thiyagarajan

University of Tennessee Health Science Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity”.

New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity

Journal of Medicinal Chemistry(2019)10.1021/acs.jmedchem.8b00973

N/A

0.631DataRank · unranked

66 citations

Yali He, Suriyan Ponnusamy, Michael L. Mohler, Thirumagal Thiyagarajan, Iain J. McEwan +3 more

Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice

PLoS ONE(2020)10.1371/journal.pone.0230499

N/A

0DataRank · unranked

16 citations

Jessalyn Rodgers, Thirumagal Thiyagarajan, Bethany J. Wolf, Evelyn Bruner, Kamala Sundararaj +3 more